Jisuk Jo

696 total citations
7 papers, 296 citations indexed

About

Jisuk Jo is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jisuk Jo has authored 7 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Jisuk Jo's work include Lymphoma Diagnosis and Treatment (2 papers), Lung Cancer Treatments and Mutations (2 papers) and RNA modifications and cancer (1 paper). Jisuk Jo is often cited by papers focused on Lymphoma Diagnosis and Treatment (2 papers), Lung Cancer Treatments and Mutations (2 papers) and RNA modifications and cancer (1 paper). Jisuk Jo collaborates with scholars based in South Korea, United States and United Kingdom. Jisuk Jo's co-authors include Jinseon Lee, Young Tae Kim, Hyuk‐Jin Cha, Ji‐Seon Lee, So‐Jung Choi, Kwhanmien Kim, Dae‐Soon Son, Hyun Joo Lee, Youngah Shin and Bumjin Kim and has published in prestigious journals such as Cancer Research, Oncotarget and BMC Cancer.

In The Last Decade

Jisuk Jo

7 papers receiving 294 citations

Peers

Jisuk Jo

MB

ONCOL

CR

PFM

PRM

Hae Yoen Jung South Korea

Lillian Pliner United States

Jintong Ji China

Kimberly F. Kerstann United States

Chaojie Wang United States

Chun Zhuang China

Yang Bao China

Dao Doan United States

Anke Meyer Germany

Eunjin Bae South Korea

Hae Yoen Jung South Korea

Jisuk Jo

183 ×1.1

MB

78 ×0.8

ONCOL

58 ×1.0

CR

64 ×1.2

PFM

40 ×1.1

PRM

Citations per year, relative to Jisuk Jo Jisuk Jo (= 1×) peers Hae Yoen Jung

Countries citing papers authored by Jisuk Jo

Since Specialization

Citations

This map shows the geographic impact of Jisuk Jo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jisuk Jo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jisuk Jo more than expected).

Fields of papers citing papers by Jisuk Jo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jisuk Jo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jisuk Jo. The network helps show where Jisuk Jo may publish in the future.

Co-authorship network of co-authors of Jisuk Jo

This figure shows the co-authorship network connecting the top 25 collaborators of Jisuk Jo. A scholar is included among the top collaborators of Jisuk Jo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jisuk Jo. Jisuk Jo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Hong, Jung Yong, Min Eui Hong, Moon Ki Choi, et al.. (2015). The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.. PubMed. 35(4). 2465–74. 13 indexed citations

2.

Yoon, Heejei, Sanghui Park, Sang Yun Ha, et al.. (2015). Integrated copy number and gene expression profiling analysis of epstein–barr virus‐positive diffuse large b‐cell lymphoma. Genes Chromosomes and Cancer. 54(6). 383–396. 37 indexed citations

3.

Choi, So‐Jung, Ji‐Seon Lee, Jisuk Jo, et al.. (2013). Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer. Oncotarget. 4(12). 2512–2522. 123 indexed citations

4.

Sun, Jong‐Mu, Ji‐Youn Sung, Se Hoon Park, et al.. (2012). ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy. BMC Cancer. 12(1). 187–187. 29 indexed citations

5.

Kang, Minwoong, Jisuk Jo, Joungho Han, et al.. (2009). Stage III Thymic Epithelial Neoplasms are Not Homogeneous with Regard to Clinical, Pathological, and Prognostic Features. Journal of Thoracic Oncology. 4(12). 1561–1567. 9 indexed citations

6.

Lee, Hyun Joo, Jisuk Jo, Dae‐Soon Son, et al.. (2009). Predicting Recurrence Using the Clinical Factors of Patients with Non-small Cell Lung Cancer After Curative Resection. Journal of Korean Medical Science. 24(5). 824–824. 7 indexed citations

7.

Kim, Bumjin, Hyun Joo Lee, Hye Young Choi, et al.. (2007). Clinical Validity of the Lung Cancer Biomarkers Identified by Bioinformatics Analysis of Public Expression Data. Cancer Research. 67(15). 7431–7438. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact